<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1353325</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1353325</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Traditional Chinese medicine Zhusha Anshen Wan: protective effects on liver, kidney, and intestine of the individual drugs using <sup>1</sup>H NMR metabolomics</article-title>
<alt-title alt-title-type="left-running-head">Wang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1353325">10.3389/fphar.2024.1353325</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Dalu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1547353/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Chong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Beixing</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1115803/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Haifeng</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/371292/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of General Surgery</institution>, <institution>Shengjing Hospital of China Medical University</institution>, <addr-line>Shenyang</addr-line>, <addr-line>Liaoning</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Traditional Chinese Materia Medica</institution>, <institution>Shenyang Pharmaceutical University</institution>, <addr-line>Shenyang</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pathogenic Biology</institution>, <institution>School of Basic Medical Science</institution>, <institution>China Medical University</institution>, <addr-line>Shenyang</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1600927/overview">Yi Wu</ext-link>, Nanjing Agricultural University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2212424/overview">Dongyan Zhang</ext-link>, Penn State Milton S. Hershey Medical Center, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1329165/overview">Chang Li</ext-link>, Harbin Medical University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Beixing Liu, <email>bxliu@cmu.edu.cn</email>; Haifeng Wang, <email>wanghaifeng0310@163.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1353325</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>01</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Wang, Yu, Liu and Wang.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Wang, Yu, Liu and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Introduction:</bold> Zhusha Anshen Wan (ZSASW) is a traditional Chinese medicine compound mainly composed of mineral drugs. In clinical practice, ZSASW did not show the toxicity of administering equal doses of cinnabar alone, suggesting that the four combination herbs in ZSASW can alleviate the damage of cinnabar. The effect of each herb on reducing the toxicity of cinnabar has not been fully explained.</p>
<p>
<bold>Methods:</bold> In our study, we utilized a metabonomics approach based on high-resolution 1H nuclear magnetic resonance spectroscopy to investigate the reduction of toxicity by each herb in ZSASW. Liver, kidney and intestinal histopathology examinations and biochemical analysis of the serum were also performed.</p>
<p>
<bold>Results:</bold> Partial least squares-discriminant analysis (PLS-DA) was conducted to distinct different metabolic profiles in the urine and serum from the rats. Liver and kidney histopathology examinations, as well as analysis of serum clinical chemistry analysis, were also carried out. The metabolic profiles of the urine and serum of the rats in the CGU (treated with cinnabar and <italic>Glycyrrhiza uralensis</italic> Fisch) and CCC (treated with cinnabar and <italic>Coptis chinensis</italic> French) groups were remarkably similar to those of the control group, while those of the CRG (treated with cinnabar and <italic>Rehmannia glutinosa</italic> Libosch) and CAS (treated with cinnabar and <italic>Angelica sinensis</italic>) groups were close to those of the cinnabar group. The metabolic profiles of the urine and serum of the rats in the CGU and CCC groups were remarkably similar to those of the control group, while those of the CRG and CAS groups were close to those of the cinnabar group. Changes in endogenous metabolites associated with toxicity were identified. <italic>Rehmannia glutinosa</italic>, <italic>Rhizoma Coptidis</italic> and <italic>Glycyrrhiza uralensis</italic> Fisch could maintain the dynamic balance of the intestinal flora. These results were also verified by liver, kidney and intestinal histopathology examinations and biochemical analysis of the serum. The results suggested that</p>
<p>
<bold>Discussion:</bold> The metabolic mechanism of single drug detoxification in compound prescriptions has been elucidated. <italic>Coptis chinensis</italic> and <italic>Glycyrrhiza uralensis</italic> serve as the primary detoxification agents within ZSASW for mitigating liver, kidney, and intestinal damage caused by cinnabar. Detoxification can be observed through changes in the levels of various endogenous metabolites and related metabolic pathways.</p>
</abstract>
<kwd-group>
<kwd>metabonomics</kwd>
<kwd>
<sup>1</sup>H NMR spectroscopy</kwd>
<kwd>detoxification</kwd>
<kwd>cinnabar</kwd>
<kwd>intestinal flora</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Ethnopharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Mercurials such as cinnabar (96% as HgS) have been used in traditional Chinese medicines (TCMs) as tranquilizers (<xref ref-type="bibr" rid="B28">Wang et al., 2007</xref>; <xref ref-type="bibr" rid="B13">Liu et al., 2008a</xref>). Additionally, its toxicological effects have been repeatedly reported (<xref ref-type="bibr" rid="B30">Wei et al., 2008</xref>). Mercury (Hg) is well known for its toxicity; thus, the presence of Hg in traditional medicines is great important (<xref ref-type="bibr" rid="B14">Liu et al., 2008b</xref>). Cinnabar, also called as red mercury sulfide or mercurous sulfide is a naturally occurring mineral that has been used in traditional medicine for centuries. It is available in various forms, such as powders, tablets, and capsules, and can be purchased online or at health food stores. Cinnabar is also used in some cosmetics and skin care products, although its use in these products is not always regulated by the FDA (<xref ref-type="bibr" rid="B27">Wang et al., 2013</xref>). Despite its long history of use in traditional medicine, cinnabar&#x2019;s toxicity was not fully recognized until recently. The primary cause of cinnabar toxicity is the consumption of large amounts of cinnabar. This can occur through the ingestion of contaminated food or water or by inadvertently consuming an excessive amount of a product containing cinnabar. In addition, cinnabars can be absorbed through the skin when applied topically (<xref ref-type="bibr" rid="B22">Saper et al., 2008</xref>). The Chinese Pharmacopoeia Committee has reduced the allowable Hg or As content in traditional medicine by as much as 65% (Pharmacopoeia of China, 2010) (<xref ref-type="bibr" rid="B34">Zhou et al., 2009</xref>), but the mercury content in these cinnabar-containing prescriptions is still thousands of-fold greater than the allowable limits in Western countries. However, many reports have indicated that these prescriptions do not have toxic effects similar to those of minerals.</p>
<p>Zhusha Anshen Wan (ZSASW) is composed of cinnabar (<italic>cinnabaris</italic>) and <italic>Coptis chinensis</italic> French. (CC), <italic>Angelica sinensis</italic> (oliv.) Diels (AS), uncooked <italic>Rehmannia glutinosa</italic> Libosch. (RG), honey fried <italic>Glycyrrhiza uralensis</italic> Fisch. Zhusha Anshen Wan is a traditional Chinese medicine formula that has been used for centuries to address a range of conditions, such as insomnia, anxiety, and depression. The formula contains several ingredients, including Zhusha (cinnabar), Anshen (Ginkgo biloba), and other herbs (<xref ref-type="bibr" rid="B35">Zhou et al., 2010</xref>). It has been shown to have beneficial effects on regulating sleep patterns in rats with insomnia (<xref ref-type="bibr" rid="B12">Li, 2008</xref>) and to enhance the calming effects of pentobarbital (<xref ref-type="bibr" rid="B6">Gao et al., 2008</xref>). Cinnabar is the primary ingredient in Zhusha Anshen Wan and is thought to have sedative and calming effects on the mind and body. It is also thought to improve blood circulation and decrease inflammation (<xref ref-type="bibr" rid="B27">Wang et al., 2013</xref>), ZSASW was significantly less toxic than cinnabar, indicating that the four combined herbs in ZSASW could alleviate the injuries induced by cinnabar. However, the effects of each herb on reducing the toxicity of cinnabar have not been fully explained.</p>
<p>Omic field techniques have been important methods in the field of systems biology. Metabonomics is a branch of systems biology that involves the quantitative measurement of the dynamic multiparametric metabolic responses of living systems to pathophysiological stimuli or genetic modifications (<xref ref-type="bibr" rid="B21">Robertson, 2005</xref>). Currently, metabonomics has been utilized in therapy monitoring, pharmaceutical discovery, and the assessment of drug efficacy and toxicity (<xref ref-type="bibr" rid="B9">Keun, 2006</xref>). This strategy aligns well with the integrative and systemic features of TCM and has been selected by several researchers to study Chinese medicine syndrome patterns (<xref ref-type="bibr" rid="B1">Buriani et al., 2012</xref>). <sup>1</sup>H NMR metabonomics is a technique used to investigate the metabolic changes that occur in cells and tissues following exposure to toxic substances. The analysis of the metabolites present in a sample involves nuclear magnetic resonance (NMR) spectroscopy. The main advantage of <sup>1</sup>H NMR metabonomics over other methods is its noninvasive nature, which enables the analysis of biological samples without causing any damage or alteration to the tissue. Additionally, metabolomics can be used to identify various types of metabolites, such as amino acids, sugars, lipids, and organic acids, which can offer valuable insights into the toxicity of a substance. Indeed, a metabonomic approach has been applied to studies of toxicity related to the use of natural medicines such as Hei-Shun-Pian and its toxic component aconitum alkaloids, and Guan-mu-tong (Aristolochia manshuriensis), which contains aristolochic acid (<xref ref-type="bibr" rid="B11">Li et al., 2008</xref>; <xref ref-type="bibr" rid="B10">Lai et al., 2009</xref>).</p>
<p>Our previous research showed that ZSASW was significantly less toxic than cinnabar (<xref ref-type="bibr" rid="B27">Wang et al., 2013</xref>). However, the potential for each herb to alleviate the toxicity of cinnabar still needs to be studied. In the current study, <sup>1</sup>H NMR spectroscopy was used to analyze the urinary and blood metabolites in rats to investigate the detoxification of each herb in ZSASW. This study demonstrated that NMR-based metabonomics analysis could be a promising approach for investigating the detoxification of Chinese medicines and the rationale behind TCM prescriptions.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Reagents and samples</title>
<p>2,2,3,3-Deuterotrimethylsilylpropionic acid (TSP) and D<sub>2</sub>O were purchased from Norell, Inc. (United States). Phosphate buffer was prepared by mixing 0.2&#xa0;M Na<sub>2</sub>HPO<sub>4</sub> and 0.2&#xa0;M NaH<sub>2</sub>PO<sub>4</sub> (pH 7.4; Sigma, St. Louis, MO, United States). Cinnabars, <italic>Coptidis Rhizoma</italic>, <italic>Angelicae Sinensis Radix, Rehmanniae Radix</italic>, and honey fried <italic>Glycyrrhizae Radix</italic> were purchased from Liaoning Tongren Pharmaceutical Co., Ltd. (Shenyang, China) and authenticated by Professor Jincai Lu (Shenyang Pharmaceutical University, China). All traditional Chinese medicine uses raw materials.</p>
</sec>
<sec id="s2-2">
<title>2.2 Animals and drug administration</title>
<p>All animal experiments were approved by the Experimental Animal Research Committee of Shenyang Pharmaceutical University (Shenyang, China, SYPU-IACUC-GZR2020-0416-203) and experiments were conducted in accordance with the relevant institutional and national guidelines and regulations. A total of 36 male Wistar rats (SPF, weighing 220 &#xb1; 20&#xa0;g; animal license no. SCXK- (military) 2007-004) were obtained from the Experimental Animal Center of Shenyang Pharmaceutical University. After a seven-day acclimatization period, the rats were kept under standard laboratory conditions, including a temperature of 25&#xb0;C &#xb1; 1&#xb0;C, relative humidity of 45% &#xb1; 15%, and a 12-h light/dark cycle. They were housed in individual metabolic cages with <italic>ad libitum</italic> access to food and water. All rats were randomly divided into 6 groups (<italic>n</italic> &#x3d; 6): control group (injected with water), cinnabar group (treated with cinnabar at dosage of 1.8&#xa0;g/kg), CAS group (treated with cinnabar and <italic>Angelica sinensis</italic> at a dosage of 1.8&#xa0;g/kg), CRG group (treated with cinnabar and <italic>Rehmannia glutinosa</italic> Libosch at a dosage of 1.8&#xa0;g/kg), CCC group (treated with cinnabar and <italic>Coptis chinensis</italic> French at a dosage of 2.7&#xa0;g/kg), and CGU group (treated with cinnabar and <italic>Glycyrrhiza uralensis</italic> Fisch at a dosage of 0.9&#xa0;g/kg) (<xref ref-type="bibr" rid="B30">Wei et al., 2008</xref>).</p>
</sec>
<sec id="s2-3">
<title>2.3 Sample collection and pretreatment</title>
<p>Urine samples were collected overnight on dry ice in tubes containing 1&#xa0;mL of 1% sodium azide (from PM 8:00 to AM 8:00). These samples were immediately frozen and stored at &#x2212;20&#xb0;C until they were prepared for NMR spectroscopic analysis. At the end of the experimental period (day nine), all animals were sacrificed, and blood was drawn from the inferior vena cava. Serum was obtained by centrifugation at 14,000&#xa0;rpm for 10&#xa0;min at 4&#xb0;C. All the serum samples were stored at &#x2212;80&#xb0;C until further analysis. Livers and kidneys were removed from the rats and immersed in 10% neutral buffered formaldehyde solution (Sigma, St. Louis, MO, United States) for histopathology experiments.</p>
</sec>
<sec id="s2-4">
<title>2.4 Serum biochemical analysis and histopathology examination</title>
<p>The liver, kidney and intestinal tract tissues were dehydrated, embedded in paraffin, and cut at 5&#xa0;&#x3bc;m thickness. The sliced sections were stained with hematoxylin and eosin (H&#x26;E) and examined via light microscopy (&#xd7;200). The serum biochemical test included the following parameters: aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), glucose (GLU), creatinine (CREA), triglyceride (TG), total protein (TP), cholesterol (CHO) and carbamide (UREA).</p>
</sec>
<sec id="s2-5">
<title>2.5 <sup>1</sup>H NMR spectroscopic measurements of urine and serum samples</title>
<p>Five hundred microliters of a thawed urine sample was mixed with 200&#xa0;&#x3bc;L of phosphate buffer (0.2&#xa0;M, pH 7.4) and centrifuged at 8000&#xa0;rpm for 10&#xa0;min to remove insoluble material. Five hundred microliters of supernatant was placed into a 5&#xa0;mm NMR tube containing 50&#xa0;&#x3bc;L (TSP, 0.1%, w/v) and 60&#xa0;&#x3bc;L D<sub>2</sub>O. NMR spectral measurements were acquired on a Bruker-Av600 spectrometer at 298&#xa0;K. Typically, 32 free induction decays (FIDs) were collected into 64&#xa0;k data points over a spectral width of 12019.23&#xa0;Hz with a relaxation delay of 3&#xa0;s and an acquisition time of 2.73&#xa0;s. The number of scans was 64.</p>
<p>Frozen serum samples were thawed, and 400&#xa0;&#x3bc;L of serum was mixed with 60&#xa0;&#x3bc;L of D<sub>2</sub>O and 40&#xa0;&#x3bc;L of TSP and transferred to 5&#xa0;mm NMR tubes. TSP acted as an internal standard reference (<italic>&#x3b4;</italic> 0.00&#xa0;ppm), and D<sub>2</sub>O was used for the locking signal. <sup>1</sup>H NMR spectra of these samples were also recorded on a Bruker-Av600 spectrometer at 298&#xa0;K. The pulse program was a 1D experiment with a T<sub>2</sub> filter using the Carr&#x2012;Purcell&#x2012;Meiboom&#x2012;Gill sequence. Thirty-two FIDs were collected into 64&#xa0;k data points over a spectral width of 12019.23&#xa0;Hz with a relaxation delay of 3&#xa0;s and an acquisition time of 2.73&#xa0;s. The power level for presaturation was 50&#xa0;dB, and the number of scans was also 64.</p>
</sec>
<sec id="s2-6">
<title>2.6 Data reduction analysis of <sup>1</sup>H NMR spectra</title>
<p>Baseline-corrected and manual phase adjustments of the spectra were performed. The <sup>1</sup>H NMR spectra from urine or serum were segmented into 192 integrated regions of equal width (0.04&#xa0;ppm), corresponding to the region <italic>&#x3b4;</italic> 0.2&#x2013;10.0, using MestReNova 9.0.1 (Mestrelab Research SL.). The area for each segmented region was calculated, and the integral values contributed to an intensity distribution of the whole spectrum. The region (<italic>&#x3b4;</italic> 4.2&#x2013;5.0) was deleted to remove any spurious effects of variability in the suppression of water resonance. For the urine spectra, the region containing urea (<italic>&#x3b4;</italic> 5.2&#x2013;6.0) was also excluded to eliminate any consequent chemical exchange effects on the urea signal. All remaining regions of the spectra were then scaled to the total integrated area of the spectra to reduce any significant concentration differences.</p>
<p>Finally, all the spectral data were normalized to a constant integrated intensity. The data set was mean centered, meaning that the average peak intensity across all samples was set to zero. PLS-DA-based multivariate data analysis was performed using the SIMCA-P 13.0 software package (Umetrics AB, Umea, Sweden).</p>
<p>The goodness of fit of each model was evaluated using three quantitative parameters: R<sup>2</sup>X was the explained variation in X, R<sup>2</sup>Y was the explained variation in Y, and Q<sup>2</sup>Y was the predicted variation in Y. The range of these parameters was between 0 and 1, with values approaching 1 indicating a perfect fit of the model. (<xref ref-type="bibr" rid="B15">Liu et al., 2010</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Clinical biochemistry and histopathology</title>
<p>To verify the presence of liver damage in each group of rats, the serum levels of AST, ALT, ALP, TP, UREA, CREA, TG, CHO, and GLU were measured. The biochemical changes in the serum are presented in <xref ref-type="table" rid="T1">Table 1</xref>. Significantly increased levels of serum AST and ALP were found in the cinnabar and CRG groups compared with those in the control group. However, there were no significant changes in the levels of urea, glucose or creatinine among the CCC and CGU groups.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Selected clinical biochemical parameters of serum. The data are presented as the means &#xb1; SDs of six animals per group.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Biochemical parameters</th>
<th align="center">Control</th>
<th align="center">Cinnabar</th>
<th align="center">CAS</th>
<th align="center">CRG</th>
<th align="center">CGU</th>
<th align="center">CCC</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">AST (U/L)</td>
<td align="center">94.50 &#xb1; 19.07</td>
<td align="center">115.17 &#xb1; 16.24<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">80.60 &#xb1; 13.97</td>
<td align="center">106.50 &#xb1; 16.22</td>
<td align="center">96.83 &#xb1; 26.24</td>
<td align="center">94.67 &#xb1; 16.12</td>
</tr>
<tr>
<td align="center">ALT (U/L)</td>
<td align="center">34.00 &#xb1; 9.01</td>
<td align="center">39.00 &#xb1; 8.72</td>
<td align="center">32.40 &#xb1; 5.64</td>
<td align="center">41.67 &#xb1; 2.80<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">35.50 &#xb1; 5.50</td>
<td align="center">39.33 &#xb1; 8.09</td>
</tr>
<tr>
<td align="center">ALP (U/L)</td>
<td align="center">262.83 &#xb1; 105.27</td>
<td align="center">293.17 &#xb1; 47.82<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">253.80 &#xb1; 74.34</td>
<td align="center">314.17 &#xb1; 56.39<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">283.17 &#xb1; 80.02</td>
<td align="center">267.17 &#xb1; 54.55</td>
</tr>
<tr>
<td align="center">TP (g/L)</td>
<td align="center">61.58 &#xb1; 11.94</td>
<td align="center">71.62 &#xb1; 6.74</td>
<td align="center">63.56 &#xb1; 11.43</td>
<td align="center">77.35 &#xb1; 7.78<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">65.68 &#xb1; 15.41</td>
<td align="center">67.68 &#xb1; 15.76</td>
</tr>
<tr>
<td align="center">UREA (lmol/L)</td>
<td align="center">12.88 &#xb1; 3.70</td>
<td align="center">10.87 &#xb1; 0.86</td>
<td align="center">10.74 &#xb1; 1.67</td>
<td align="center">12.05 &#xb1; 2.05</td>
<td align="center">10.47 &#xb1; 2.51<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">10.58 &#xb1; 1.61</td>
</tr>
<tr>
<td align="center">CREA (lmol/L)</td>
<td align="center">20.00 &#xb1; 4.86</td>
<td align="center">18.17 &#xb1; 3.43</td>
<td align="center">17.00 &#xb1; 2.83<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">20.83 &#xb1; 5.04</td>
<td align="center">18.17 &#xb1; 6.24<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">17.83 &#xb1; 3.06<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
</tr>
<tr>
<td align="center">TG (mmol/L)</td>
<td align="center">0.64 &#xb1; 0.21</td>
<td align="center">0.72 &#xb1; 0.22</td>
<td align="center">0.62 &#xb1; 0.30</td>
<td align="center">0.62 &#xb1; 0.20</td>
<td align="center">0.52 &#xb1; 0.11</td>
<td align="center">0.45 &#xb1; 0.13</td>
</tr>
<tr>
<td align="center">CHO (mmol/L)</td>
<td align="center">1.63 &#xb1; 0.46</td>
<td align="center">1.55 &#xb1; 0.34</td>
<td align="center">1.50 &#xb1; 0.34<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">1.62 &#xb1; 0.15</td>
<td align="center">1.30 &#xb1; 0.59<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">1.23 &#xb1; 0.33</td>
</tr>
<tr>
<td align="center">GLU (mmol/L)</td>
<td align="center">12.79 &#xb1; 2.44</td>
<td align="center">14.17 &#xb1; 1.47</td>
<td align="center">13.97 &#xb1; 2.22<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">15.79 &#xb1; 1.57<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">13.05 &#xb1; 3.44</td>
<td align="center">13.64 &#xb1; 2.06</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>
<sup>a</sup>
</label>
<p>
<italic>p</italic> &#x3c; 0.05 compared to the control.</p>
</fn>
<fn id="Tfn2">
<label>
<sup>b</sup>
</label>
<p>
<italic>p</italic> &#x3c; 0.05 compared to cinnabar.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>As demonstrated in <xref ref-type="fig" rid="F1">Figure 1</xref>, the main lesions in the cinnabar and CAS groups exhibited diffuse hepatocyte degeneration, necrosis, and apoptosis. Significant swelling (ballooning degeneration) (<xref ref-type="fig" rid="F2">Figure 2</xref>) of hepatocytes was also observed in the cinnabar, CAS and CRG groups. On the other hand, no liver or renal damage was observed in the control group, CCC group or CGU group.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Liver histopathology of rats. Livers from the control <bold>(A)</bold>, CAS <bold>(B)</bold>, CGU <bold>(C)</bold>, cinnabar <bold>(D)</bold>, CRG <bold>(E)</bold>, and CCC <bold>(F)</bold> groups.</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Kidney histopathology of rats. Kidneys from the control <bold>(A)</bold>, CAS <bold>(B)</bold>, CGU <bold>(C)</bold>, cinnabar <bold>(D)</bold>, CRG <bold>(E)</bold>, and CCC <bold>(F)</bold> groups.</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g002.tif"/>
</fig>
<p>After the administration of cinnabar, most red blood cells in the intestinal cavity of the rats appeared as blood. Most inflammatory cells can be observed in the intestinal chorion. No abnormalities were found in the intestinal cavity or chorionic membrane of the other administration groups, including the control group (<xref ref-type="fig" rid="F3">Figure 3</xref>). The above results indicate that other Chinese herbs in Zhusha Anshenwan may have potential protective effects on intestinal injury caused by cinnabar.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Intestinal histopathology of rats. Kidneys from the control <bold>(A)</bold>, CAS <bold>(B)</bold>, CGU <bold>(C)</bold>, cinnabar <bold>(D)</bold>, CRG <bold>(E)</bold>, and CCC <bold>(F)</bold> groups.</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g003.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Analysis of <sup>1</sup>H NMR spectral data of urine</title>
<p>Many endogenous metabolites were observed in the <sup>1</sup>H NMR spectra of urine from the control, cinnabar, CAS, CGU, CRG, and CCC groups on day 9 (<xref ref-type="fig" rid="F4">Figure 4</xref>). Assignments of endogenous metabolites involved in <sup>1</sup>H NMR spectra were based on the literature (<xref ref-type="bibr" rid="B8">Jung et al., 2011</xref>; <xref ref-type="bibr" rid="B24">Tang et al., 2012</xref>). The main endogenous metabolites, such as leucine, isoleucine, 3-hydroxybutyrate (3-HB), acetate, 2-ketoglutarate (2-OG), citrate, lactate, creatine, alanine, trimethylamine-<italic>N</italic>-oxide (TMAO), glycine, hippurate, formate, phenylalanine, creatinine and succinate, were identified (<xref ref-type="fig" rid="F4">Figure 4</xref>). To illustrate the differences in the metabolic profiles, a PLS-DA score plot based on <sup>1</sup>H NMR spectra of urine from the 6 groups is shown in <xref ref-type="fig" rid="F5">Figure 5</xref>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>600&#xa0;MHz <sup>1</sup>H NMR spectra of urine from the cinnabar group <bold>(A)</bold>, control group <bold>(B)</bold>, CCC group <bold>(C)</bold>, CAS group <bold>(D)</bold>, CRG group <bold>(E)</bold>, and CGU group <bold>(F)</bold>. Keywords: 1, leucine &#x2b; isoleucine; 2,3-hydroxybutyrate (3-HB); 3, acetate; 4,2-ketoglutarate (2-OG); 5, citrate; 6, lactate; 7, creatine; 8, alanine; 9, trimethylamine-<italic>N</italic>-oxide (TMAO); 10, glycine; 11, hippurate; 12, formate; 13, phenylalanine; 14, creatinine; 15, succinate; 16, taurine.</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>PLS-DA score plot derived from <sup>1</sup>H NMR spectra of urine from the 6 groups (R<sup>2</sup>X &#x3d; 0.453, Q<sup>2</sup> &#x3d; 0.318). Keywords: control group (<inline-graphic xlink:href="fphar-15-1353325-fx1.tif"/>); CCC group (<inline-graphic xlink:href="fphar-15-1353325-fx2.tif"/>); CGU group (<inline-graphic xlink:href="fphar-15-1353325-fx3.tif"/>); cinnabar group (<inline-graphic xlink:href="fphar-15-1353325-fx4.tif"/>); CAS group (<inline-graphic xlink:href="fphar-15-1353325-fx5.tif"/>); CRG group (<inline-graphic xlink:href="fphar-15-1353325-fx6.tif"/>).</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g005.tif"/>
</fig>
<p>As shown in <xref ref-type="fig" rid="F5">Figure 5</xref>, the PLS-DA results, as scores for the first two principal components from the spectra of the six groups, revealed that the CGU and CCC groups were distributed in the area of the control group, while the CAS and CRG groups were close to the cinnabar group. To investigate the impact of each herb in ZSASW on metabolic changes in detail, comparisons among the control and compatibility groups of cinnabars (CAS, CRG, CCC, CGU) were carried out using the PLS-DA model (<xref ref-type="fig" rid="F6">Figures 6</xref>, <xref ref-type="fig" rid="F7">7</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>PLS-DA score plot <bold>(A)</bold> and corresponding loading plot <bold>(B)</bold> based on <sup>1</sup>H NMR spectra of urine from the control group, cinnabar group and CAS group (R<sup>2</sup>X &#x3d; 0.545, Q<sup>2</sup> &#x3d; 0.352). PLS-DA score plot <bold>(C)</bold> and corresponding loading plot <bold>(D)</bold> based on <sup>1</sup>H NMR spectra of urine from the control group, cinnabar group and CRG group (R<sup>2</sup>X &#x3d; 0.577, Q<sup>2</sup> &#x3d; 0.353). Key: control group (<inline-graphic xlink:href="fphar-15-1353325-fx1.tif"/>); group CAS (<inline-graphic xlink:href="fphar-15-1353325-fx5.tif"/>); group CRG (<inline-graphic xlink:href="fphar-15-1353325-fx6.tif"/>); group cinnabar (<inline-graphic xlink:href="fphar-15-1353325-fx4.tif"/>).</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g006.tif"/>
</fig>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>PLS-DA score plot <bold>(A)</bold> and corresponding loading plot <bold>(B)</bold> based on <sup>1</sup>H NMR spectra of urine from the control group, cinnabar group and CGU group (R<sup>2</sup>X &#x3d; 0.557, Q<sup>2</sup> &#x3d; 0.428). PLS-DA score plot <bold>(C)</bold> and corresponding loading plot <bold>(D)</bold> based on <sup>1</sup>H NMR spectra of urine from the control group, cinnabar group and CCC group (R<sup>2</sup>X &#x3d; 0.466, Q<sup>2</sup> &#x3d; 0.324). Key: control group (<inline-graphic xlink:href="fphar-15-1353325-fx1.tif"/>); group CGU (<inline-graphic xlink:href="fphar-15-1353325-fx2.tif"/>); group CCC (<inline-graphic xlink:href="fphar-15-1353325-fx3.tif"/>); group cinnabar (<inline-graphic xlink:href="fphar-15-1353325-fx4.tif"/>).</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g007.tif"/>
</fig>
<p>In the PLS-DA-derived score plots (<xref ref-type="fig" rid="F6">Figures 6A, C</xref>), the clusters of the cinnabar and CAS groups as well as the CRG were easily distinguished from those of the control group. The loading plots (<xref ref-type="fig" rid="F6">Figures 6B, D</xref>) showed the relevant changes in endogenous metabolites responsible for the separation, which included increased alanine, lactate, TMAO, taurine, hippurate, phenylalanine, 3-HB, creatine and creatinine and decreased 2-OG, succinate, and citrate in the cinnabar, CAS and CRG groups compared with those in the control group.</p>
<p>However, from the PLS-DA score plots (<xref ref-type="fig" rid="F7">Figures 7A, C</xref>), separation of the cinnabar group from the control, CGU and CCC groups was observed. By examining the corresponding loading plots (<xref ref-type="fig" rid="F7">Figures 7B, D</xref>) and NMR spectra, the separation was attributed to depleted alanine, lactate, TMAO, phenylalanine, 3-HB, creatine and creatinine with elevated citrate, succinate, 2-OG, and hippurate in the CGU and CCC groups compared to the cinnabar group.</p>
<p>The endogenous metabolites in urine samples and their changes in different groups based on the analyses of the loading plots and the <sup>1</sup>H NMR-detected relative integral levels are listed in <xref ref-type="table" rid="T2">Table 2</xref>.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Endogenous metabolites selected as biomarkers in urine profiles and their change trends.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Endogenous metabolites</th>
<th align="center">Chemical shifts</th>
<th align="center">Cinnabar VS Control</th>
<th align="center">CAS VS Cinnabar</th>
<th align="center">CRG VS Cinnabar</th>
<th align="center">CGU VS Cinnabar</th>
<th align="center">CCC VS Cinnabar</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">citrate</td>
<td align="center">2.72 (d), 2.56 (d)</td>
<td align="center">&#x2193;</td>
<td align="left">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
</tr>
<tr>
<td align="center">TMAO</td>
<td align="center">3.26 (s)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">succinate</td>
<td align="center">2.42 (s)</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
</tr>
<tr>
<td align="center">2-OG</td>
<td align="center">3.01 (t), 2.45 (t)</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
</tr>
<tr>
<td rowspan="2" align="center">hippurate</td>
<td align="center">7.73 (d), 7.64 (t), 7.55 (t)</td>
<td rowspan="2" align="center">&#x2193;</td>
<td rowspan="2" align="center">&#x2191;</td>
<td rowspan="2" align="center">&#x2191;</td>
<td rowspan="2" align="center">&#x2191;</td>
<td rowspan="2" align="center">&#x2191;</td>
</tr>
<tr>
<td align="center">3.97 (d)</td>
</tr>
<tr>
<td align="center">formate</td>
<td align="center">8.47 (s)</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
</tr>
<tr>
<td align="center">taurine</td>
<td align="center">3.43 (t), 3.26 (t)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
</tr>
<tr>
<td align="center">creatine</td>
<td align="center">3.94 (s), 3.04 (s)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">creatinine</td>
<td align="center">4.05 (s), 3.05 (s)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">phenylalanine</td>
<td align="center">7.37 (m), 7.42 (m)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">lactate</td>
<td align="center">4.11 (q), 1.33 (d)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">glycine</td>
<td align="center">3.55 (s)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">3-HB</td>
<td align="center">1.23 (d)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">alanine</td>
<td align="center">1.48 (d)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">acetate</td>
<td align="center">1.92 (s)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The levels of potential biomarkers are labeled with (&#x2193;) indicating a decrease and (&#x2191;) indicating an increase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-3">
<title>3.3. Analysis of <sup>1</sup>H NMR spectral data of serum</title>
<p>The <sup>1</sup>H NMR spectra of the serum of rats in different groups are shown in <xref ref-type="fig" rid="F8">Figure 8</xref>. The metabolite signals that were assigned to the proton region of the <sup>1</sup>H NMR spectra included those corresponding to creatinine, creatine, valine, alanine, TMAO, pyruvate, choline, lactate, <italic>&#x3b1;</italic>-glucose, leucine and isoleucine (<xref ref-type="bibr" rid="B17">Nicholls et al., 2001</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>600&#xa0;MHz <sup>1</sup>H NMR spectra of serum from the cinnabar group <bold>(A)</bold>, control group <bold>(B)</bold>, CCC group <bold>(C)</bold>, CAS group <bold>(D)</bold>, CRG group <bold>(E)</bold>, and CGU group <bold>(F)</bold>. Key: 1, creatinine; 2, creatine; 3, valine; 4, alanine; 5, TMAO; 6, pyruvate; 7, choline; 8, lactate; 9, <italic>&#x3b1;</italic>-glucose; 10, leucine &#x2b; isoleucine; 11, acetate.</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g008.tif"/>
</fig>
<p>The PLS-DA score plot based on <sup>1</sup>H NMR spectra of the serum from the six groups is shown in <xref ref-type="fig" rid="F9">Figure 9</xref>. The points of the CCC and CGU groups were classified to the region of the control group, while the cinnabar, CAS and CRG groups were mapped together.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>PLS-DA score plot derived from <sup>1</sup>H NMR spectra of serum from the 6 groups (R<sup>2</sup>X &#x3d; 0.682, Q<sup>2</sup> &#x3d; 0.598). Key: control group (<inline-graphic xlink:href="fphar-15-1353325-fx1.tif"/>); group CCC (<inline-graphic xlink:href="fphar-15-1353325-fx2.tif"/>); group CAS (<inline-graphic xlink:href="fphar-15-1353325-fx3.tif"/>); group cinnabar (<inline-graphic xlink:href="fphar-15-1353325-fx4.tif"/>); group CGU (<inline-graphic xlink:href="fphar-15-1353325-fx5.tif"/>); group CRG (<inline-graphic xlink:href="fphar-15-1353325-fx6.tif"/>).</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g009.tif"/>
</fig>
<p>The PLS-DA score plots (<xref ref-type="fig" rid="F10">Figures 10A, C</xref>) showed that the cinnabar, CAS and CRG groups were well discriminated from the control group. The loading plot (<xref ref-type="fig" rid="F10">Figures 10B, D</xref>) revealed that the difference was attributed to an increase in the levels of creatinine, creatine, valine, alanine, TMAO, leucine and isoleucine as well as a reduction in the level of lactate in the cinnabar, CAS and CRG groups compared with the control group.</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>PLS-DA score plot <bold>(A)</bold> and corresponding loading plot <bold>(B)</bold> based on <sup>1</sup>H NMR spectra of serum from the control group, cinnabar group and CAS group (R<sup>2</sup>X &#x3d; 0.545, Q<sup>2</sup> &#x3d; 0.352). PLS-DA score plot <bold>(C)</bold> and corresponding loading plot <bold>(D)</bold> based on <sup>1</sup>H NMR spectra of serum from the control group, cinnabar group and CRG group (R<sup>2</sup>X &#x3d; 0.577, Q<sup>2</sup> &#x3d; 0.353). Key: control group (<inline-graphic xlink:href="fphar-15-1353325-fx1.tif"/>); group CAS (<inline-graphic xlink:href="fphar-15-1353325-fx5.tif"/>); group CRG (<inline-graphic xlink:href="fphar-15-1353325-fx6.tif"/>); group cinnabar (<inline-graphic xlink:href="fphar-15-1353325-fx4.tif"/>).</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g010.tif"/>
</fig>
<p>The performance of the score plots (<xref ref-type="fig" rid="F11">Figures 11A, C</xref>) reflected discrimination where the control, CCC and CGU groups were separate from the cinnabar group. The corresponding loading plots (<xref ref-type="fig" rid="F11">Figures 11B, D</xref>) and <sup>1</sup>H NMR spectra showed that the main biochemical changes in the serum were decreased creatinine, creatine, valine, alanine, TMAO, leucine and isoleucine with increased choline, pyruvate and lactate in the control, CCC and CGU groups compared with the cinnabar group.</p>
<fig id="F11" position="float">
<label>FIGURE 11</label>
<caption>
<p>PLS-DA score plot <bold>(A)</bold> and corresponding loading plot <bold>(B)</bold> based on <sup>1</sup>H NMR spectra of serum from the control group, cinnabar group and CGU group (R<sup>2</sup>X &#x3d; 0.508, Q<sup>2</sup> &#x3d; 0.412). PLS-DA score plot <bold>(C)</bold> and corresponding loading plot <bold>(D)</bold> based on <sup>1</sup>H NMR spectra of serum from the control group, cinnabar group and CCC group (R<sup>2</sup>X &#x3d; 0.466, Q<sup>2</sup> &#x3d; 0.324). Key: control group (<inline-graphic xlink:href="fphar-15-1353325-fx1.tif"/>); group CCC (<inline-graphic xlink:href="fphar-15-1353325-fx3.tif"/>); group CGU (<inline-graphic xlink:href="fphar-15-1353325-fx2.tif"/>); group cinnabar (<inline-graphic xlink:href="fphar-15-1353325-fx4.tif"/>).</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g011.tif"/>
</fig>
<p>The assigned metabolites and their relative variations in serum samples from the different groups according to the PLS-DA loading plots and the <sup>1</sup>H NMR-detected relative integral levels of metabolites are listed in <xref ref-type="table" rid="T3">Table 3</xref>.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Endogenous metabolites selected as biomarkers in the serum profile and their change trends.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Endogenous metabolites</th>
<th align="center">Chemical shifts</th>
<th align="center">Cinnabar VS Control</th>
<th align="center">CAS VS Cinnabar</th>
<th align="center">CRG VS Cinnabar</th>
<th align="center">CGU VS Cinnabar</th>
<th align="center">CCC VS Cinnabar</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">creatinine</td>
<td align="left">4.05 (s), 3.05 (s)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">creatine</td>
<td align="center">3.94 (s), 3.04 (s)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">valine</td>
<td align="left">0.98 (d), 1.02 (d)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">alanine</td>
<td align="center">1.48 (d)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
</tr>
<tr>
<td align="center">TMAO</td>
<td align="center">3.26 (s)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
<tr>
<td align="center">pyruvate</td>
<td align="center">2.38 (s)</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
</tr>
<tr>
<td align="center">choline</td>
<td align="center">3.18 (s)</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
</tr>
<tr>
<td align="center">lactate</td>
<td align="center">4.11 (q),1.33 (d)</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
</tr>
<tr>
<td align="center">leucine &#x2b; isoleucine</td>
<td align="center">0.96&#x2013;1.0 (m)</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2191;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
<td align="center">&#x2193;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The levels of potential biomarkers are labeled with (&#x2193;) indicating a decrease and (&#x2191;) an increase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-4">
<title>3.4 Pathway analysis</title>
<p>In addition, to identify the most relevant pathways associated with cinnabar-induced acute hepatic injury, a comprehensive metabolic network was constructed using MetaboAnalyst 3.0. A total of sixteen biomarkers underwent pathway analysis via metaboanalyst 3.0 (<ext-link ext-link-type="uri" xlink:href="http://www.metaboanalyst.ca">http://www.metaboanalyst.ca</ext-link>), and the metabolic pathways associated with each substance and their FDR values are summarized in <xref ref-type="fig" rid="F12">Figure 12</xref>. Pathways with an impact value &#x3e;0.1 were considered the most relevant pathways to liver injury. In this study, the biosynthesis of valine, leucine, and isoleucine; as well as the metabolism of taurine and hypotaurine, phenylalanine, glycine, serine, and threonine, glyoxylate and dicarboxylate, and the TCA cycle pathways were identified as important metabolic pathways, with impact factors of 0.67, 0.42 0.41, 0.29, 0.29, and 0.15, respectively. Pathway analysis indicated that the alleviation effect of each herb in ZSASW was connected to alterations in energy metabolism and amino acid metabolism.</p>
<fig id="F12" position="float">
<label>FIGURE 12</label>
<caption>
<p>Summary of pathway analysis.</p>
</caption>
<graphic xlink:href="fphar-15-1353325-g012.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>Our previous research investigated the liver and kidney toxicity of cinnabar. However, at the toxic dose, no corresponding damage was detected in the zhusha Anshen wan. We speculate that each single traditional Chinese medicine in the formula has a certain protective effect on the damage caused by cinnabar. Based on the relationship of the various traditional Chinese medicine combinations in the formula, in order to provide a better basis for the rational clinical use of the formula, we conducted a preliminary exploration of the detoxification effect of each single drug on cinnabar in the Zhusha Anshen wan.</p>
<p>Succinate, citrate, and 2-OG are the three key intermediates in the TCA cycle. The TCA cycle is a series of chemical reactions that breakdown glucose into energy molecules such as ATP. Downregulation of the TCA cycle may lead to a reduction in the levels of cinnabar and CAS groups. The tricarboxylic acid (TCA) cycle is a metabolic pathway that converts glucose into energy molecules, including ATP (<xref ref-type="bibr" rid="B16">Mart&#xed;nez-Reyes et al., 2016</xref>). Succinate is converted back to citric acid, which is then further converted to CO<sub>2</sub> and used for respiration. However, succinate, citrate, and 2-OG tended to reverse the changes observed in the CCC and CGU groups, indicating that the herbs <italic>Coptis chinensis</italic> and <italic>Glycyrrhiza uralensis</italic> Fisch could reverse energy metabolism.</p>
<p>On the other hand, lower ATP disrupts mitochondrial function, leading to higher AMP concentrations. We observed high levels of alanine, an intermediate of anaerobic metabolism, in the serum of the cinnabar and CRG groups. An increase in amino acids, such as alanine and phenylalanine, was also observed in the rats treated with cinnabar, CAS, or CRG, which indicated disruption of hepatic amino acid metabolism. This could have resulted from hepatic damage or depletion of hepatic ATP induced by cinnabar treatment. Elevated levels of branched-chain amino acids (leucine and valine) were observed in the serum of cinnabar and CAS groups. A notable rise in alanine in the serum was also observed after cinnabar or CRG treatment. This finding implies that cinnabar disrupts hepatic amino acid metabolism. It is also thought that the loss of absorption capacity of the proximal tubules by cinnabar increases the excretion of amino acids such as alanine, isoleucine, leucine and valine. Moreover, the herbs <italic>Coptis chinensis</italic> and <italic>Glycyrrhiza uralensis</italic> Fisch reversed the increase in alanine, phenylalanine and lactate in the urine, which suggested that these two herbs could prevent liver and kidney damage induced by cinnabar.</p>
<p>It appears that betaine primarily affects peripheral tissues. Additionally, it has been reported that TMAO in plasma is produced through the following pathway: dietary phosphatidylcholine/choline &#x2192; gut flora-formed TMA &#x2192; hepatic FMO-formed TMAO (<xref ref-type="bibr" rid="B5">Feng et al., 2014</xref>), which was elevated in the rats in the cinnabar and CAS groups. The development of hydropic degeneration due to the hypotonic conditions of the extracellular fluid could associate with elevated levels of TMAO and betaine. A high level of urinary TMAO (an osmolyte mentioned above), commonly associated with osmotic stress in the renal medulla and a signal of drug-induced nephrotoxicity (<xref ref-type="bibr" rid="B4">Feng et al., 2002</xref>), supporting evidence for renal medullary damage, could also be found from the exfoliated epithelial cells and proteins in the lumen of the renal medulla as noted in the histopathological analysis. <italic>Rehmannia glutinosa</italic>, <italic>Rhizoma Coptidis</italic> and <italic>Glycyrrhiza uralensis</italic> Fisch reversed the increase in urine TMAO concentration induced by cinnabar, which indicated that these three herbal medicines might have protective effects on cinnabar-induced renal injury.</p>
<p>Taurine possesses numerous essential properties, including antioxidant effects, regulation of Ca<sup>2&#x2b;</sup> flux, membrane stabilization, osmoregulation, and attenuation of apoptosis (<xref ref-type="bibr" rid="B20">Rashid et al., 2013</xref>). Increased taurine levels have long been recognized as a specific indicator of liver toxicity in the urine (<xref ref-type="bibr" rid="B29">Waterfield et al., 1991</xref>). In the current study, the urinary taurine concentration was elevated in the cinnabar and CAS groups. These changes were accompanied by necrosis and steatosis, which correlated with the observed hepatocyte necrosis in histopathology. Furthermore, the significant increase in the serum AST concentration also provided evidence of hepatic injury. However, the taurine content was reduced by <italic>Rehmannia glutinosa</italic> in the CRG group. The level of taurine in the CRG was close to that in the control group. These results suggest that <italic>Rehmannia glutinosa</italic> could regulate the disruption of taurine metabolism caused by cinnabar.</p>
<p>Additionally, the urinary excretion of creatine and creatinine significantly increased, indicating that cinnabar impaired glomerular filtration function. Histopathological examination revealed evident kidney injury and dysfunction, characterized by vascular dilatation and congestion in the nephron. Additionally, elevated plasma creatinine levels were observed in the biochemical analysis. The fluctuations in biomarker concentrations and histopathology results indicated that <italic>Coptis chinensis</italic> and <italic>Glycyrrhiza uralensis</italic> in ZSASW were the main detoxification materials used for the liver and kidney damage induced by cinnabar.</p>
<p>
<italic>Coptis chinensis</italic> (Huanglian) is a commonly used traditional Chinese medicine (TCM) herb, and alkaloids are the most important chemical constituents (<xref ref-type="bibr" rid="B23">Sun et al., 2014</xref>; <xref ref-type="bibr" rid="B2">Dai et al., 2016</xref>). Alkaloids reportedly have protective effects on the liver (<xref ref-type="bibr" rid="B7">Heidari et al., 2017</xref>; <xref ref-type="bibr" rid="B31">Wu et al., 2017</xref>). Furthermore, berberine, which is the main alkaloid in <italic>Coptis chinensis</italic>, could restore normal hepatic mitochondrial respiration (<xref ref-type="bibr" rid="B26">Teodoro et al., 2013</xref>). Analysis of the metabolic pathways associated with endogenous metabolites revealed that energy metabolism was involved in the detoxification mechanism. Therefore, one of the material criteria for the detoxification of cinnabars might be the presence of alkaloids in <italic>Coptis chinensis</italic>. <italic>Glycyrrhiza uralensis</italic> is one of the most popular herbal medicines worldwide and contains a large array of saponins (<xref ref-type="bibr" rid="B25">Tao et al., 2013</xref>; <xref ref-type="bibr" rid="B3">Farag et al., 2015</xref>). The pharmacological effects of <italic>Glycyrrhiza uralensis</italic> include the inhibition of gastric ulcers; anti-inflammatory, antiviral, and therapeutic effects on liver ailments have been well verified (<xref ref-type="bibr" rid="B3">Farag et al., 2015</xref>; <xref ref-type="bibr" rid="B19">Qiao et al., 2015</xref>; <xref ref-type="bibr" rid="B32">Yuan et al., 2016</xref>). The biological effects are attributed to the major biologically active constituents: terpenoids, alkaloids and saponins (<xref ref-type="bibr" rid="B33">Zhang and Ye, 2009</xref>). Glycyrrhizic acid (GA) is a natural constituent isolated from the dried roots of the genus <italic>Glycyrrhiza</italic>. GA has a potent protective effect against hepatotoxicity. Pretreatment with GA significantly decreased ALT, AST and ALP, attenuated the histopathology of hepatic injury, decreased the apoptotic index, ameliorated oxidative stress in hepatic tissue, and increased the activities of SOD and GPx (<xref ref-type="bibr" rid="B18">Orazizadeh et al., 2014</xref>). In combination with our experimental results, we concluded that <italic>Glycyrrhiza uralensis</italic> may have a detoxifying effect on cinnabar-induced injury, probably because it contains saponins, especially larger amounts of glycyrrhizic acid.</p>
<p>Choline can be broken down by the intestinal microbiota into methylamine metabolites, including DMA, TMA, and TMAO. The level of TMAO in the urine of cinnabar-treated rats was elevated, indicating that the choline metabolism of the intestinal microbiota accelerated under the pressure of cinnabar. <italic>Rehmannia glutinosa</italic>, <italic>Rhizoma Coptidis</italic> and <italic>Glycyrrhiza uralensis</italic> Fisch could reverse the increase in urine TMAO concentration induced by cinnabar, which indicated that these three kinds of herbal medicine might regulate intestinal disorders caused by cinnabar and maintain the dynamic balance of the intestinal flora. In addition, hipp is an important metabolite of amino acids in the intestinal microbiota. Hipps are formed by the combination of glycine and benzoate in liver tissue.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>The results clearly showed that the metabolic profiles of the CCC and CGU groups were remarkably similar to those of the control group. The variation tendencies of the CAS and CRG groups were similar to that of the cinnabar group. In this study, the effects of the main detoxification herbs in ZSASW on liver and kidney damage induced by cinnabar were investigated using <sup>1</sup>H NMR-based metabonomics for the first time. <sup>1</sup>H NMR spectroscopy, along with histopathology and clinical biochemical assays, provided valuable insight into the relationship between metabolite changes and tissue toxicity. The associated biochemical pathways related to energy metabolism, amino acid metabolism, and gut microbiota disorders offer new insights for assessing the detoxification of each herb in ZSASW from a comprehensive and systematic perspective.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The data presented in the study are available within the article or supplementary material.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>The animal studies were approved by the national legislations of China. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent was obtained from the owners for the participation of their animals in this study.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>DW: Data curation, Project administration, Resources, Validation, Visualization, Writing&#x2013;review and editing. CY: Formal Analysis, Investigation, Methodology, Project administration, Supervision, Validation, Writing&#x2013;original draft. BL: Data curation, Investigation, Methodology, Resources, Visualization, Writing&#x2013;review and editing. HW: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Software, Writing&#x2013;original draft.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (Project No. 30973867).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2024.1353325/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2024.1353325/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet5.xls" id="SM1" mimetype="application/xls" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet3.xls" id="SM2" mimetype="application/xls" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet2.xls" id="SM3" mimetype="application/xls" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet4.xls" id="SM4" mimetype="application/xls" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buriani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garcia-Bermejo</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Bosisio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future</article-title>. <source>J. Ethnopharmacol.</source> <volume>140</volume>, <fpage>535</fpage>&#x2013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2012.01.055</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>S.-Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.-Y.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Establishment and reliability evaluation of the design space for HPLC analysis of six alkaloids in Coptis chinensis (Huanglian) using Bayesian approach</article-title>. <source>Chin. J. Nat. Med.</source> <volume>14</volume>, <fpage>697</fpage>&#x2013;<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1016/S1875-5364(16)30083-8</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farag</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Porzel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wessjohann</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Unequivocal glycyrrhizin isomer determination and comparative <italic>in vitro</italic> bioactivities of root extracts in four Glycyrrhiza species</article-title>. <source>J. Adv. Res.</source> <volume>6</volume>, <fpage>99</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.jare.2014.05.001</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>1H NMR analysis for metabolites in serum and urine from rats administrated chronically with La(NO3)3</article-title>. <source>Anal. Biochem.</source> <volume>301</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1006/abio.2001.5471</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>
<sup>1</sup>H-NMR metabonomics study of the therapeutic mechanism of total alkaloids and ajmalicine from Rauvolfia verticillata in spontaneously hypertensive rats</article-title>. <source>Anal. Methods</source> <volume>6</volume>, <fpage>6473</fpage>&#x2013;<lpage>6482</lpage>. <pub-id pub-id-type="doi">10.1039/c4ay00851k</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Studies on the main pharmacological effects of tongren&#x27;anshen pill <italic>in vivo</italic>
</article-title>. <source>J. Cap. Med. Univ.</source> <volume>29</volume>, <fpage>74</fpage>&#x2013;<lpage>77</lpage>.</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heidari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Moezi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ommati</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Azarpira</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Hepatoprotective effect of boldine in a bile duct ligated rat model of cholestasis/cirrhosis</article-title>. <source>PharmaNutrition</source> <volume>5</volume>, <fpage>109</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.phanu.2017.07.001</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Shim</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>&#xb9;H NMR-based metabolic profiling of naproxen-induced toxicity in rats</article-title>. <source>Toxicol. Lett.</source> <volume>200</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2010.09.020</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keun</surname>
<given-names>H. C.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Metabonomic modeling of drug toxicity</article-title>. <source>Pharmacol. Ther.</source> <volume>109</volume>, <fpage>92</fpage>&#x2013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2005.06.008</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>J. S.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid</article-title>. <source>Nephrol. Carlt. Vic.)</source> <volume>14</volume>, <fpage>227</fpage>&#x2013;<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1797.2008.01061.x</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Metabonomic study on the toxicity of Hei-Shun-Pian, the processed lateral root of Aconitum carmichaelii Debx. (Ranunculaceae)</article-title>. <source>J. Ethnopharmacol.</source> <volume>116</volume>, <fpage>561</fpage>&#x2013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2008.01.014</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>T. L.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Influence of decoction of"Zhusha anshen Pill"on sleep phase in insomnia rats</article-title>. <source>Shanghai J. Traditional Chin. Med</source>.</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Goyer</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Waalkes</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2008a</year>). <article-title>Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite</article-title>. <source>J. Pharmacol. Exp. Ther.</source> <volume>326</volume>, <fpage>363</fpage>&#x2013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.108.139543</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J.-Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.-M.</given-names>
</name>
<name>
<surname>Goyer</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Waalkes</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2008b</year>). <article-title>Mercury in traditional medicines: is cinnabar toxicologically similar to common mercurials?</article-title> <source>Exp. Biol. Med. (Maywood, N.J.)</source> <volume>233</volume>, <fpage>810</fpage>&#x2013;<lpage>817</lpage>. <pub-id pub-id-type="doi">10.3181/0712-MR-336</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Aa</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Differences in metabolite profile between blood plasma and serum</article-title>. <source>Anal. Biochem.</source> <volume>406</volume>, <fpage>105</fpage>&#x2013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.ab.2010.07.015</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mart&#xed;nez-Reyes</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lauren</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schieber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hensley</surname>
<given-names>C. T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>TCA cycle and mitochondrial membrane potential are necessary for diverse biological functions</article-title>. <source>Mol. Cell</source> <volume>61</volume>, <fpage>199</fpage>&#x2013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2015.12.002</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicholls</surname>
<given-names>A. W.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lindon</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Shockcor</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Farrant</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Haselden</surname>
<given-names>J. N.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Metabonomic investigations into hydrazine toxicity in the rat</article-title>. <source>Chem. Res. Toxicol.</source> <volume>14</volume>, <fpage>975</fpage>&#x2013;<lpage>987</lpage>. <pub-id pub-id-type="doi">10.1021/tx000231j</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orazizadeh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fakhredini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mansouri</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Khorsandi</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Effect of glycyrrhizic acid on titanium dioxide nanoparticles-induced hepatotoxicity in rats</article-title>. <source>Chemico-biological Interact.</source> <volume>220</volume>, <fpage>214</fpage>&#x2013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2014.07.001</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>D.-a.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Separation and characterization of phenolic compounds and triterpenoid saponins in licorice (Glycyrrhiza uralensis) using mobile phase-dependent reversed-phase&#xd7;reversed-phase comprehensive two-dimensional liquid chromatography coupled with mass spectrometry</article-title>. <source>J. Chromatogr. A</source> <volume>1402</volume>, <fpage>36</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.chroma.2015.05.006</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rashid</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sil</surname>
<given-names>P. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Taurine ameliorate alloxan induced oxidative stress and intrinsic apoptotic pathway in the hepatic tissue of diabetic rats</article-title>. <source>Food Chem. Toxicol.</source> <volume>51</volume>, <fpage>317</fpage>&#x2013;<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2012.10.007</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>D. G.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Metabonomics in toxicology: a review</article-title>. <source>Toxicol. Sci.</source> <volume>85</volume>, <fpage>809</fpage>&#x2013;<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfi102</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saper</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Sehgal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khouri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Paquin</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet</article-title>. <source>Jama</source> <volume>300</volume>, <fpage>915</fpage>&#x2013;<lpage>923</lpage>. <pub-id pub-id-type="doi">10.1001/jama.300.8.915</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Preparative separation of quaternary ammonium alkaloids from Coptis chinensis Franch by pH-zone-refining counter-current chromatography</article-title>. <source>J. Chromatogr. A</source> <volume>1370</volume>, <fpage>156</fpage>&#x2013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.chroma.2014.10.043</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>1H NMR-based metabonomics study of the urinary biochemical changes in Kansui treated rat</article-title>. <source>J. Ethnopharmacol.</source> <volume>141</volume>, <fpage>134</fpage>&#x2013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2012.02.011</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Comparison of three officinal Chinese pharmacopoeia species of Glycyrrhiza based on separation and quantification of triterpene saponins and chemometrics analysis</article-title>. <source>Food Chem.</source> <volume>141</volume>, <fpage>1681</fpage>&#x2013;<lpage>1689</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2013.05.073</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teodoro</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>F. V.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Varela</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Peixoto</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Rolo</surname>
<given-names>A. P.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation</article-title>. <source>Mitochondrion</source> <volume>13</volume>, <fpage>637</fpage>&#x2013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2013.09.002</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>A metabolic profiling analysis of the acute hepatotoxicity and nephrotoxicity of Zhusha Anshen Wan compared with cinnabar in rats using (1)H NMR spectroscopy</article-title>. <source>J. Ethnopharmacol.</source> <volume>146</volume>, <fpage>572</fpage>&#x2013;<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2013.01.026</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>The anxiolytic effect of cinnabar involves changes of serotonin levels</article-title>. <source>Eur. J. Pharmacol.</source> <volume>565</volume>, <fpage>132</fpage>&#x2013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2007.03.018</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waterfield</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Turton</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Scales</surname>
<given-names>M. D. C.</given-names>
</name>
<name>
<surname>Timbrell</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Taurine, a possible urinary marker of liver damage: a study of taurine excretion in carbon tetrachloride-treated rats</article-title>. <source>Archives Toxicol.</source> <volume>65</volume>, <fpage>548</fpage>&#x2013;<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1007/BF01973715</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>227</volume>, <fpage>417</fpage>&#x2013;<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2007.11.015</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.-T.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.-X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.-W.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Urinary metabonomics study of the hepatoprotective effects of total alkaloids from Corydalis saxicola Bunting on carbon tetrachloride-induced chronic hepatotoxicity in rats using 1H NMR analysis</article-title>. <source>J. Pharm. Biomed. Analysis</source> <volume>140</volume>, <fpage>199</fpage>&#x2013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2017.03.031</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Ferulic acid attenuated acetaminophen-induced hepatotoxicity though down-regulating the cytochrome P 2E1 and inhibiting toll-like receptor 4 signaling-mediated inflammation in mice</article-title>. <source>Am. J. Transl. Res.</source> <volume>8</volume>, <fpage>4205</fpage>&#x2013;<lpage>4214</lpage>.</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Chemical analysis of the Chinese herbal medicine Gan-Cao (licorice)</article-title>. <source>J. Chromatogr. A</source> <volume>1216</volume>, <fpage>1954</fpage>&#x2013;<lpage>1969</lpage>. <pub-id pub-id-type="doi">10.1016/j.chroma.2008.07.072</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Progresses on mechanisms of pharmacological and toxicological effects of cinnabar</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source> <volume>34</volume>, <fpage>2843</fpage>&#x2013;<lpage>2847</lpage>.</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>
<italic>In vitro</italic> studies on dissolved substance of cinnabar: chemical species and biological properties</article-title>. <source>J. Ethnopharmacol.</source> <volume>131</volume>, <fpage>196</fpage>&#x2013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2010.06.018</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>